Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
[11 C]PHNO is a D 2/D 3 agonist positron emission tomography radiotracer, with higher in vivo affinity for D 3 than for D 2 receptors. As [11 C]-( + )-PHNO is an agonist, its in vivo binding is expected to be more affected by acute fluctuations in synaptic dopamine than that of antagonist radiotracers such as [11 C]raclopride. In this study, the authors compared the effects of an oral dose of the dopamine releaser amphetamine (0.3 mg/kg) on in vivo binding of [11 C]-( + )-PHNO and [11 C]raclopride in healthy subjects, using a within-subjects, counterbalanced, open-label design. In the dorsal striatum, where the density of D 3 receptors is negligible and both tracers predominantly bind to D2 receptors, the reduction of [11 C]-( + )-PHNO binding potential ( BP ND) was 1.5 times larger than that of [11 C]raclopride. The gain in sensitivity associated with the agonist [11 C]-( + )-PHNO implies that ~65% of D 2 receptors are in the high-affinity state in vivo. In extrastriatal regions, where [11 C]-( + )-PHNO predominantly binds to D 3 receptors, the amphetamine effect on [11 C]-( + )-PHNO BP ND was even larger, consistent with the higher affinity of dopamine for D 3. This study indicates that [11 C]- ( + )-PHNO is superior to [11 C]raclopride for studying acute fluctuations in synaptic dopamine in the human striatum. [11 C]-( + )-PHNO also enables measurement of synaptic dopamine in D 3 regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationBreier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 2×
“A dosedependent relationship between amphetamine dose and changes in ligand binding (Breier et al, 1997; Hartvig et al, 1997; Laruelle et al, 1997), as well as a consistent relationship between the concentration of extracellular dopamine change and the change in radioligand binding (Breier et al,…”
BackgroundImaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Self-citationAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 1×
“These figures are larger than those reported in [11C]raclopride studies using similar doses of amphetamine, which generally lie between 5% and 15% (Drevets et al, 2001; Leyton et al, 2002; Munro et al, 2006; Oswald et al, 2005).”
ResultLeyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Oswald, L. M., Wong, D. F., McCaul, M., Zhou, Y., Kuwabara, H., Choi, L., Brasic, J., & Wand, G. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300667 · Cited by 314 · cited 1×
“These figures are larger than those reported in [11C]raclopride studies using similar doses of amphetamine, which generally lie between 5% and 15% (Drevets et al, 2001; Leyton et al, 2002; Munro et al, 2006; Oswald et al, 2005).”
ResultPET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122 · cited 1×
“Journal of Cerebral Blood Flow & Metabolism (2012) 32, 127–136 dopamine release in the VST is approximately twice that in the dorsal striatum (Drevets et al, 1999).”
BackgroundWilleit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107 · cited 5×
“(Willeit et al, 2008).”
BackgroundResultInfluentialSkinbjerg, M., Liow, J.-S., Seneca, N., Hong, J., Lu, S., Thorsell, A., Heilig, M., Pike, V. W., Halldin, C., Sibley, D. R., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.055 · Cited by 86
Hartvig, P., Torstenson, R., Tedroff, J., Watanabe, Y., Fasth, K. J., Bjurling, P., & L�ngstr�m, B. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277655 · Cited by 70 · cited 1×
“A dosedependent relationship between amphetamine dose and changes in ligand binding (Breier et al, 1997; Hartvig et al, 1997; Laruelle et al, 1997), as well as a consistent relationship between the concentration of extracellular dopamine change and the change in radioligand binding (Breier et al,…”
Background
Cited by
The dopamine theory of addiction: 40 years of highs and lows
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3939 · Cited by 649
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
Tziortzi, A. C., Haber, S. N., Searle, G. E., Tsoumpas, C., Long, C. J., Shotbolt, P., Douaud, G., Jbabdi, S., Behrens, T. E. J., Rabiner, E. A., et al. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs397 · Cited by 315
Self-citationIncreased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198
Boileau, I., Payer, D., Chugani, B., Lobo, D., Behzadi, A., Rusjan, P. M., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., et al. (2013) · Addiction · doi:10.1111/add.12066 · Cited by 190
Cho, S. S., Koshimori, Y., Aminian, K., Obeso, I., Rusjan, P., Lang, A. E., Daskalakis, Z. J., Houle, S., & Strafella, A. P. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.211 · Cited by 112
Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., Wilson, A. A., Houle, S., & Rusjan, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.347 · Cited by 101
Finnema, S. J., Stepanov, V., Ettrup, A., Nakao, R., Amini, N., Svedberg, M., Lehmann, C., Hansen, M., Knudsen, G. M., & Halldin, C. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.035 · Cited by 72
Malik, S., Jacobs, M., Cho, S.-S., Boileau, I., Blumberger, D., Heilig, M., Wilson, A., Daskalakis, Z. J., Strafella, A. P., Zangen, A., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9800-1 · Cited by 58
Gaiser, E. C., Gallezot, J.-D., Worhunsky, P. D., Jastreboff, A. M., Pittman, B., Kantrovitz, L., Angarita, G. A., Cosgrove, K. P., Potenza, M. N., Malison, R. T., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.115 · Cited by 59
Suridjan, I., Rusjan, P., Addington, J., Wilson, A. A., Houle, S., & Mizrahi, R. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110181 · Cited by 38
Nigral stress-induced dopamine release in clinical high risk and antipsychotic-naïve schizophrenia
Tseng, H.-H., Watts, J. J., Kiang, M., Suridjan, I., Wilson, A. A., Houle, S., Rusjan, P. M., & Mizrahi, R. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx042 · Cited by 31
Corticotropin-releasing hormone and dopamine release in healthy individuals
Payer, D., Williams, B., Mansouri, E., Stevanovski, S., Nakajima, S., Le Foll, B., Kish, S., Houle, S., Mizrahi, R., George, S. R., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.034 · Cited by 26
Metadata
- Authors
- Shotbolt, P., Tziortzi, A. C., Searle, G. E., Colasanti, A., van der Aart, J., Abanades, S., Plisson, C., Miller, S. R., Huiban, M., Beaver, J. D., Gunn, R. N., Laruelle, M., & Rabiner, E. A.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2011-08-31
- Volume
- 32
- Issue
- 1
- Pages
- 127-136
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2095369944
- Cited by
- 155
- References
- 10
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.